Navigation Links
Pramod Mahajan Continues to Battle for His Life

Pramod Mahajan the senior and popular BJP leader is languishing in the ICU of Hinduja Hospital in Mumbai; fighting for his life now for five days. //The big question which is in back of everyone’s mind is - if he is going to make it.

Mr.Mahajan continues to be critical despite some reduction in the drugs that are maintaining his blood pressure. Earlier Medindia has published a special report on his bullet injuries indicating the odds against him.

Dr Anupam Verma the Hospital Director said today ''Mahajan's condition has almost been the same since last night. He has however tolerated very slight reduction in requirement of medication to maintain his BP.'' ''His condition continues to remain critical and stable,'' he added.

Mr Mahajan a diabetic is on ventilator support for his lungs. However what is worrying is that his kidneys are functioning poorly and he is requiring dialysis support. The best possible care is being given by team of surgeons and intensivists with support from doctors from abroad.

It is possible that Mr.Mahajan may need a third surgery soon. His pancreas is also injured and this may be giving problems too. Initially it was the liver that kept bleeding and had to be packed with cotton.

Mr. Mahajan was shot at close range by his younger brother on Saturday morning by his younger brother Pravin at his Worli flat in Mumbai. .

Page: 1

Related medicine news :

1. Review of Pramod Mahajans Injuries
2. Pramod Mahajan Undergoes Third Surgery
3. Review of Pramod Mahajans Injuries
4. Pramod Mahajan Undergoes Third Surgery
5. 240 Hours And Counting As Mahajan Continues To Battle For Life
6. Rahul Mahajans Condition Is Serious But Stable : Hospital
7. Rahul Mahajans Condition Improving; Vital Parametres Normal
8. Police Team Permitted to Interrogate Rahul Mahajan
9. Police Summoned Apollo Doctors in Rahul Mahajan’s Cas
10. AIIMS Doctors Assists Police in Rahul Mahajan’s Drug Abuse Cas
11. Apollo doctors Summoned in Rahul Mahajan case
Post Your Comments:

(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: